2019 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
2012 | |
Criterium: | Position: |
Overall Score: | 900-1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | 70 |
Total Project Funding: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Networking Rank (Reputation): | > 1000 |
Partner Constancy: | 46 |
Project Leadership Index: | 75 |
Diversity Index: | 60 |
2011 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2019 | 0 | 5.331.000 | 406.800 | 1 | ||
2012 | 0 | 5.992.101 | 544.736 | 1 | ||
2011 | 0 | 13.329.898 | 444.022 | 1 |
Total number of partners: 45
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 45
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2019-03-01 | Neurotoxicity De-Risking in Preclinical Drug Discovery | NeuroDeRisk | participant | 5.331.000 | 18 |
2012-11-01 | Personalized diagnostics and treatment of high risk coronary artery disease patients | RISKYCAD | participant | 5.992.101 | 11 |
2011-02-01 | From data sharing and integration via VPH models to personalised medicine | p-medicine | participant | 13.329.898 | 19 |